Dluh/Vlastní kapitál společnosti Horizon Discovery plc

Jaká je hodnota metriky Dluh/Vlastní kapitál společnosti Horizon Discovery plc?

Hodnota metriky Dluh/Vlastní kapitál společnosti Horizon Discovery Group plc je 0.22

Jaká je definice metriky Dluh/Vlastní kapitál?



Poměr dluhu k vlastnímu kapitálu (debt to equity ratio) udává podíl vlastního kapitálu a cizích zdrojů na financování majetku společnosti.

The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.

Dluh/Vlastní kapitál společností v sektoru Health Care sektor na LSE ve srovnání se společností Horizon Discovery plc

Čemu se věnuje společnost Horizon Discovery plc?

Horizon Discovery Group plc, a cell engineering company, engages in the design, manufacture, and application of gene editing and gene modulation tools in the United Kingdom, the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Screening, Research Reagents, Diagnostics, and BioProduction segments. It provides custom-made and off-the-shelf (OTS) RNAi gene modulation reagents, CRISPR reagents, synthetic SGRNAs, OTS cell models, and custom cell engineering services. The company also offers pooled CRISPR screens; arrayed RNAi and CRISPR screens, drug screens, and immunology assays; and RNAi and CRISPR screening libraries; and human T-Cell CRISPR screening service to meet the requirements of immunology based research in drug discovery. In addition, it provides OTS gene-edited CHO cells and custom CHO cell lines, and custom CHO gene engineering services; and OTS cell-based reference standards, made to order reference standards, and custom cell-based reference standards to evaluate molecular assays on a research use basis. The company serves customers in academic research labs, biopharmaceutical and diagnostics companies, and contract research and manufacturing organizations. It sells its products through direct field sales channel and e-commerce platform. The company has a partnership with the Rutgers, The State University of New Jersey to develop and commercialize base editing, a gene editing technology; strategic collaboration with Mammoth Biosciences to develop CRISPR tools to provide engineered cell lines for the biopharmaceutical industry; and collaboration with St George's University Hospital, London, and the European Molecular Genetics Quality Network to develop reference material for non-invasive prenatal testing. Horizon Discovery Group plc was founded in 2007 and is headquartered in Cambridge, the United Kingdom.

Firmy s metrikou dluh/vlastní kapitál podobnou společnosti Horizon Discovery plc



  • Hodnota metriky Dluh/Vlastní kapitál společnosti Vectura Plc je 0.22
  • Hodnota metriky Dluh/Vlastní kapitál společnosti Kitex Garments je 0.22
  • Hodnota metriky Dluh/Vlastní kapitál společnosti Immuron je 0.22
  • Hodnota metriky Dluh/Vlastní kapitál společnosti JH Educational Technology INC je 0.22
  • Hodnota metriky Dluh/Vlastní kapitál společnosti Silver Viper Minerals je 0.22
  • Hodnota metriky Dluh/Vlastní kapitál společnosti Maxicity je 0.22
  • Hodnota metriky Dluh/Vlastní kapitál společnosti Horizon Discovery plc je 0.22
  • Hodnota metriky Dluh/Vlastní kapitál společnosti Bajaj Auto je 0.22
  • Hodnota metriky Dluh/Vlastní kapitál společnosti Graco je 0.22
  • Hodnota metriky Dluh/Vlastní kapitál společnosti Mi Ming Mart je 0.22
  • Hodnota metriky Dluh/Vlastní kapitál společnosti KuangChi Science je 0.22
  • Hodnota metriky Dluh/Vlastní kapitál společnosti Singular Health Ltd je 0.22
  • Hodnota metriky Dluh/Vlastní kapitál společnosti Strong Petrochemical je 0.22